Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab

The coronavirus disease 2019 (COVID-19) pandemic has become an urgent global health issue. An older age and underlying conditions, such as diabetes, have been reported as risk factors, but whether or not autoimmune diseases increase the risk remains unknown. An 85-year-old man with Sjögren's sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Kodama, Fumihiro, Tomita, Tomoko, Kondo, Makoto, Nagasaka, Atsushi, Nishikawa, Shuji, Mukai, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946515/
https://www.ncbi.nlm.nih.gov/pubmed/33390490
http://dx.doi.org/10.2169/internalmedicine.6010-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946515/
https://www.ncbi.nlm.nih.gov/pubmed/33390490
http://dx.doi.org/10.2169/internalmedicine.6010-20

Ejemplares similares